XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Note 1 - Business and Organization (Details Textual)
3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2017
Number of Wholly-Owned Subsidiaries 6           6      
Revenue from Contract with Customer, Including Assessed Tax $ 2,672,000     $ 1,500,000     $ 7,860,000 $ 3,786,000    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest (1,508,000) $ (1,626,000) $ (494,000) (847,000) $ (1,333,000) $ (1,544,000) (3,628,000) (3,724,000)    
Net Cash Provided by (Used in) Operating Activities             (2,363,000) $ (2,803,000)    
Working Capital (Deficit) 2,951,000           2,951,000      
Assets, Current 4,691,000           4,691,000   $ 3,153,000  
Stock Issued During Period, Value, New Issues 203,000 494,000 800,000 $ 1,117,000 $ 948,000 $ 1,202,000        
Cash and Cash Equivalents, at Carrying Value 3,042,000           3,042,000   $ 1,851,000  
Vehicle Loan [Member]                    
Long-Term Debt 71,000           71,000      
SBA CARES Act Paycheck Protection Program [Member]                    
Long-Term Debt 140,000           140,000      
Economic Injury Disaster Loan [Member]                    
Long-Term Debt 148,000           148,000      
Inventory Line of Credit [Member] | Clyra Medical Technologies [Member]                    
Long-Term Line of Credit $ 234,000           234,000      
The 2020 Unit Offering [Member]                    
Stock Issued During Period, Value, New Issues             995,000      
Lincoln Park Capital Fund, LLC [Member]                    
Stock Issued During Period, Value, New Issues             $ 502,000      
Clyra Medical Technologies [Member]                    
Subsidiary, Ownership Percentage, Parent 53.00%           53.00%      
Noncontrolling Interest, Increase from Subsidiary Equity Issuance $ 288,000 $ 1,062,000 225,000       $ 1,575,000      
BioLargo Engineering, Science & Technologies, LLC [Member]                    
Subsidiary, Ownership Percentage, Parent                   100.00%
BioLargo Engineering, Science & Technologies, LLC [Member] | Approximation [Member]                    
Subsidiary, Ownership Percentage, Parent 82.00%           82.00%      
BioLargo Energy Technologies, Inc (BETI) [Member]                    
Subsidiary, Ownership Percentage, Parent 96.00%           96.00%      
Noncontrolling Interest, Increase from Subsidiary Equity Issuance     $ 550,000       $ 905,000